CannabisDNA analyzes an individual’s genetic signature with a proprietary algorithm that calculates the predisposition for health conditions that are directly modulated by cannabis. The test also features information concerning how an individual metabolizes cannabinoids, which affects their cannabis experience.
Your genes play a large role in determining how your body and nervous system react to cannabis. Many cannabis components belong to a class of molecules known as cannabinoids, while others belong to a molecular class known as terpenes. THC and CBD, the two most abundant cannabinoids, mediate their physiological effects through a cellular signaling pathway known as Endocannabinoid System (ECS). The ECS, which is depicted in the figure below, features prominently in a number of physiological systems and biological processes, including metabolism, appetite, pain, sleep, mood, learning and memory, cardiovascular function, gastrointestinal function, the immune system, and neural development.
Due to a combination of variables, including personal genetics and individual health concerns, a cannabis product and/or cannabinoid combination that is optimal for one individual may not be suitable for another person. This is because different strains and cannabinoids are effective at treating different conditions. Each individual, due to their own personal genetics, will tolerate and respond to the components of cannabis in a personalized manner. By accounting for such variables, CannabisDNA assesses your predisposition to the effects of cannabis and uses this information to provide you with a detailed, personalized report informing you as to which cannabis strains and products are optimal for your health and well-being.
Not only does CannabisDNA provide you with an extensive list of available strains and products, it also delves into the chemistry of cannabinoids by addressing factors such as concentration, purity, and forms of delivery. Finally, CannabisDNA provides you with a scientific overview of the underlying relationship between cannabis and human health and disease.
Our proprietary algorithm is supported by robust findings from premium peer-reviewed research articles. We selected genetic markers from studies that incorporate large population sizes with significant associations to the traits included in this report. Our goal is to use our proprietary algorithm to provide you with a personalized report that will optimized for you.
Instead of using other error-prone methods, like QPCR or array-based testing, as our competitors do, Pathway uses a comprehensive NGS testing platform that delivers more accurate and comprehensive results. Gene targeting regions are PCR amplified, enriched and sequenced by Next-Generation Sequencing (NGS). Our onsite laboratory at Pathway is: